WinstonWınston
Back
Ansell Limited logo

Ansell Limited

ANN.AX
51
Medical - Instruments & Supplies · Healthcare
Exchange
Australian Securities Exchange
Winston Score
51
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Dec 31, 2025
How the score breaks down
Quality
Good
Growth
Mixed
Cash Flow
Strong
Stability
Strong
Valuation
Strong
Dividends
Strong

Winston Score History

The full picture

Ansell Limited makes protective gloves, clothing, and other safety gear worn by people in hospitals, factories, and laboratories. Its main products include surgical gloves, exam gloves, and industrial protective suits sold to healthcare workers, manufacturers, and chemical handlers around the world. Ansell is one of the largest dedicated protective equipment companies globally, with well-known brands like GAMMEX and HyFlex.

Ansell earns money by selling its products directly to hospitals, distributors, and industrial companies, operating across two main segments: Health & Protection and Industrial & Protection. The company sells in over 55 countries, with significant revenue from North America, Europe, and Asia, and generates roughly $1.6 billion in annual sales. Its moat comes from strong brand recognition, regulatory certifications that take years to obtain, and deep customer relationships in safety-critical industries. The key risk is that demand for its healthcare gloves remains well below the spike seen during the COVID-19 pandemic, and the company must grow its industrial segment to offset that ongoing pressure.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+22.2% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

-23.3% YoY

YoY Growth Rate

Earnings declining

Insider Activity

0.0%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

A$239M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

Ansell Limited is a rare growth stock that's already generating positive cash flow while growing at 22%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
40.8%
Healthy — 40.8% gross margin
Profit after running costs
Operating Margin
13.6%
Healthy — 13.6% operating margin
Return on the money invested
ROCE
8.3%
Below par — 8.3% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+11.4%
Steady sales growth (+11.4% YoY)
Profit growth
EPS YoY
+18.5%
Earnings growing fast (+18.5% YoY)

Healthy double-digit earnings growth — what compounders look like.

How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
174%
Turns 174% of profit into real cash
Spare cash per sale
FCF Margin
8.3%
Modest free cash flow (8.3%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.42
Conservative — low debt load (0.42)
Covers its interest
Interest Cover
5.01x
Adequate interest coverage (5.0x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
26.2x
no trend
Growth-priced — P/E 26.2

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
+9.3
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (26.2 → 16.8)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
2.26%
no trend
Moderate income — 2.26% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record
Dividend Growth
+17.8%
no trend
Dividend growing fast (17.8% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial